CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis

Immunobiology

Volumn 216, Issue 9, 2011, Pages 1004-1009

  Abu El Asrar, Ahmed M ^a   Al Obeidan, Saleh S ^a   Kangave, Dustan ^a   Geboes, Karel ^b   Opdenakker, Ghislain ^c   Van Damme, Jo ^c   Struyf, Sofie ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Beh et's disease; Chemokines; HLA B27; Uveitis; Vogt Koyanagi Harada disease

Indexed keywords

ALPHA CHEMOKINE; CORTICOSTEROID; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; CYCLOSPORIN A; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; STROMAL CELL DERIVED FACTOR 1;

ADOLESCENT; ADULT; AQUEOUS HUMOR; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TREATMENT OUTCOME; UVEITIS; VOGT KOYANAGI SYNDROME;

EID: 79960816258     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.03.007     Document Type: Article

References (35)

1. Abu El-Asrar A.M., Struyf S., Descamps F.J., Al-Obeidan S.A., Proost P., Van Damme J., Opdenakker G., Geboes K. Chemokines and gelatinases in the aqueous humor of patients with active uveitis. Am. J. Ophthalmol. 2004, 138:401-411.
2. Abu El-Asrar A.M., Struyf S., Kangave D., Al-Obeidan S.A., Opdenakker G., Geboes K., Van Damme J. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin. Immunol. 2011, January. [Epub ahead of print].
3. Ahn J.K., Yu H.G., Chung H., Park Y.G. Intraocular cytokine environment in active Behçet's uveitis. Am. J. Ophthalmol. 2006, 142:429-434.
4. Biasi D., Carletto A., Caramaschi P., Bellavite P., Andrioli G., Caraffi M., Pacor M.L., Bambara L.M. Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin. Exp. Rheumatol. 1995, 13:623-627.
5. Bizzarri C., Beccari A.R., Bertini R., Cavicchia M.R., Giorgini S., Allegretti M. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol. Ther. 2006, 112:139-149.
6. Christen U., McGavern D.B., Luster A.D., von Herrath M.G., Oldstone M.B.A. Among CXCR3 chemokines, IFN-γ-inducible protein of 10KDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-γ (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 2003, 171:6838-6845.
7. Ergun T., Gürbüz O., Harvell J., Jorizzo J., White W. The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behçet's disease. Int. J. Dermatol. 1998, 37:929-933.
8. Fang I.M., Yang C.H., Lin C.P., Yang C.M., Chen M.S. Expression of chemokine receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp. Eye Res. 2004, 78:1043-1055.
9. Gouwy M., Struyf S., Proost P., Van Damme J. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev. 2005, 16:561-580.
10. Gül A., Esin S., Dilsen N., Koniçe M., Wigzell H., Biberfeld P. Immunohistology of skin pathergy reaction in Behçet's disease. Br. J. Dermatol. 1995, 132:901-907.
11. Gurnow S.J., Falciani F., Durrani O.M., Cheung C.M.G., Ross E.J., Wloka K., Rauz S., Wallace G.R., Salmon M., Murray P.I. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest. Ophthalmol. Vis. Sci. 2005, 46:4251-4259.
12. Hanaoka R., Kasama T., Muramatsu M., Yajima N., Shiozawa F., Miwa Y., Negishi M., Ide H., Miyaoka H., Uchida H., Adachi M. A novel mechanism for the regulation of IFN-γ inducible protein-10 expression in rheumatoid arthritis. Arthritis Res. Ther. 2003, 5:R74-R81.
13. Imai Y., Ohno S. Helper T-cell subsets in uveitis. Int. Ophthalmol. Clin. 2002, 42:25-32.
14. International Study Group for Behçet's disease Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080.
15. Keino H., Takeuchi M., Kezuka T., Yamakawa N., Tsukahara R., Usui M. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice. Graefes Arch. Clin. Exp. Ophthalmol. 2003, 241:111-115.
16. Kemp E.H., Metcalfe R.A., Smith K.A., Woodroofe M.N., Watson P.F., Weetman A.P. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin. Endocrinol. 2003, 59:207-213.
17. Kong K.O., Tan A.W., Thong B.Y.H., Lian T.Y., Cheng Y.K., Teh C.L., Koh E.T., Chung H.H., Law W.G., Lau T.C., Leong K.P., Leung B.P., Howe H.S. Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus. Clin. Exp. Immunol. 2009, 156:134-140.
18. Lacotte S., Brun S., Muller S., Dumortier H. CXCR3, inflammation, and autoimmune diseases. Ann. N.Y. Acad. Sci. 2009, 1173:310-317.
19. Loetscher P., Pellegrino A., Gong J.H., Mattioli I., Loetscher M., Bardi G., Baggiolini M., Clark-Lewis I. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP-10, are natural antagonists for CCR3. J. Biol. Chem. 2001, 276:2986-2991.
20. Mo J.S., Matsukawa A., Ohkawara S., Yoshinaga M. CXC chemokine GRO is essential for neutrophil infiltration in LPS-induced uveitis in rabbits. Exp. Eye Res. 2000, 70:221-226.
21. Mo J.S., Matsukawa A., Ohkawara S., Yoshinaga M. Role and regulation of IL-8 and MCP-1 in LPS-induced uveitis in rabbits. Exp. Eye Res. 1999, 68:333-340.
22. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., Power C.A. International Union of Pharmacology, XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000, 52:145-176.
23. Nishioji K., Okanoue T., Itoh Y., Narumi S., Sakamoto M., Nakamura H., Morita A., Kashima K. Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. Clin. Exp. Immunol. 2001, 123:271-279.
24. Ogawa N., Ping L., Zhenjun L., Takada Y., Sugai S. Involvement of the interferon-γ-induced T cell-attracting chemokines, interferon-γ-inducible 10-KDa protein (CXCL10) and monokine induced by interferon-γ (CXCL9) in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum. 2002, 46:2730-2741.
25. Pay S., Simsek I., Erdem H., Dinç A. Immunopathogenesis of Behçet's disease with special emphasis on the possible role of antigen presenting cells. Rheumatol. Int. 2007, 27:417-424.
26. Qi X.F., Kim D.H., Yoon Y.S., Jin D., Huang X.Z., Li J.H., Deung Y.K., Lee K.J. Essential involvement of cross-talk between IFN-γ and TNF-α in CXCL10 production in human THP-1 monocytes. J. Cell. Physiol. 2009, 220:690-697.
27. Read R.W., Holland G.N., Rao N.A., Tabbara K.F., Ohno S., Arellanes-Garcia L., Pivetti-Pezzi P., Tessler H.H., Usui M. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am. J. Ophthalmol. 2001, 131:647-652.
28. Romagnani P., Rotondi M., Lazzeri E., Lasagni L., Francalanci M., Buonamano A., Milani S., Vitti P., Chiovato L., Tonacchera M., Bellastella A., Serio M. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am. J. Pathol. 2002, 161:195-206.
29. Shimada K., Yaoita H., Shikano S. Chemotactic activity for polymorphonuclear leucocytes of the aqueous humor in patients with Behçet's disease. Nippon Ganka Gakkai Zasshi 1971, 75:2100-2105.
30. Sørensen T.L., Sellebjerg F., Jensen C.V., Strieter R.M., Ransohoff R.M. Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis. Eur. J. Neurol. 2001, 8:665-672.
31. Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am. J. Ophthalmol. 2005, 140:509-516.
32. Stillie R., Farooq S.M., Gordon J.R., Stadnyk A.W. The functional significance behind expressing two IL-8 receptor types on PMN. J. Leukoc. Biol. 2009, 86:529-543.
33. Struyf S., Proost P., Van Damme J. Regulation of the immune response by the interaction of chemokines and proteases. Adv. Immunol. 2003, 81:1-44.
34. Verma M.J., Lloyd A., Rager H., Strieter R., Kunkel S., Taub O., Wakefield D. Chemokines in acute anterior uveitis. Curr. Eye Res. 1997, 16:1202-1208.
35. Verma M.J., Mukaida N., Vollmer-Conna U., Matsushima K., Lloyd A., Wakefield D. Endotoxin-induced uveitis is partially inhibited by anti-IL-8 antibody treatment. Invest. Ophthalmol. Vis. Sci. 1999, 40:2465-2470.